好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

The History of the Term “Catatonia” in Cases of Encephalopathy
History of Neurology
P2 - Poster Session 2 (11:45 AM-12:45 PM)
1-015

The neuropsychiatric term catatonia was born in the 19th century. We explored primary source documents to define the founder’s intent for its application in neurology and psychiatry.

Catatonia was originally described as a ‘tonic-mental disorder’ in 1874 by Dr. Karl Ludwig Kahlbaum, which included 17 distinct clinical signs or symptoms. Since its introduction to clinical medicine, the term catatonia has posed a challenge for clinicians due to its broad definition and all-encompassing symptoms.

The primary and secondary published literature on catatonia were reviewed. The first written work applied the word “die katatonie” (Greek: Kata= down, Tonus= tension) and proposed a loose definition. Subsequent publications have proposed various applications of the term.  

We will present the results of the primary literature review and the subsequent secondary publications. Our review of the criteria proposed by the Diagnostic and Statistics Manual (DSM version III, IV, and V), International Classification of Disease (ICD-11), and Busch-Francis Catatonia Screening Instrument (BFCSI) reveal that waxy flexibility and catalepsy are the most distinct features of catatonia across publications. Although widely described in the context of schizophrenia, a diverse array of etiologies has been subsequently reported, including autoimmune, substance use or withdrawal, CNS infection, and others.

Catatonia is an umbrella term usually applied to describe clinical features associated with encephalopathy. The original term was never intended to be applied as a singular diagnosis, but it was rather a descriptive term for many features now associated with encephalopathy. Establishing a consensus among psychiatrists and movement disorders neurologists is imperative to deconstruct and redefine this 150-year-old terminology.

Authors/Disclosures
Vishal Perera, MD
PRESENTER
Mr. Perera has nothing to disclose.
Abhishek Lenka, MD, PhD Mr. Lenka has nothing to disclose.
Alberto J. Espay, MD, FAAN (University of Cincinnati) Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tanabe Pharma America (formerly, Neuroderm). Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Herantis Pharma. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus (formerly USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaps Dx. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDiagnostics, Inc (SYNAPS Dx). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intrance Medical Systems, Inc.. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis Precision Medicines. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Citrus Health. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. The institution of Dr. Espay has received research support from NIH. The institution of Dr. Espay has received research support from Michael J Fox Foundation for Parkinson's Research. Dr. Espay has received intellectual property interests from a discovery or technology relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care.
Michael S. Okun, MD, FAAN (University of Florida) Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.